PROBLEM
Current cancer therapies often fail because they do not accurately reflect the composition of metastasizing cells.
TARGET GROUP
TARGET GROUP
Cancer patients, starting with breast cancer and prostate cancer, who require personalized treatment strategies. In principle, the approach can be applied to most or all tumor types.
TZU'S SOLUTION
Tzu's technology focuses on the detailed characterization of CTCs to develop therapies that can effectively target and eliminate these cells, thereby preventing metastasis. Our technology helps in early detection, reveal tumor heterogeneity and capture tumor evolution.